Stereotaxis, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Stereotaxis, Inc. on May 11, 2024, covering events occurring on May 11, 2024, and the Annual Meeting of Shareholders held on May 15, 2024. The filing primarily announces a material definitive agreement to acquire Access Point Technologies EP, Inc. (APT) and reports on shareholder voting outcomes.
Key Financial Metrics and Transaction Details
The filing does not provide standard financial metrics such as revenue, profit, cash flow, or debt levels for the reporting period. The primary financial disclosure relates to the proposed acquisition of APT:
- Consideration: Payment will be made in Stereotaxis common stock, consisting of upfront consideration and additional earnout stock.
- Share Issuance: Approximately 6.1 million shares are estimated for the resale registration statement. Upfront consideration is estimated at 25% of this total, with the remaining 75% contingent on milestone achievements.
- Valuation Method: The number of shares to be issued is based on the average closing price of Stereotaxis common stock over the five trading days ending two business days prior to the closing date.
- Termination Fee: APT has agreed to pay a termination fee of $1.0 million in certain circumstances involving a breach of solicitation restrictions.
Material Changes and Transaction Structure
The most significant material change is the entry into a Share Purchase Agreement to acquire APT, a privately held company specializing in diagnostic catheters for cardiac ablation. Key structural elements include:
- Expected Closing: Third quarter of 2024, subject to customary conditions.
- Earnout Provisions: Additional stock consideration is tied to global and US revenue targets for APT products and regulatory approvals for robotically-navigated catheters. The earnout period ends at the close of the calendar quarter following the fifth anniversary of the closing date.
- Closing Conditions: Include APT shareholder approval, absence of legal injunctions, no material adverse effect on APT, completion of APT's debt restructuring to eliminate third-party loan indebtedness, and a lease extension for APT's Minnesota facilities.
- Shareholder Support: APT shareholders holding approximately 60% of voting power have entered a Voting and Support Agreement to vote in favor of the transaction.
Shareholder Meeting Outcomes and Governance
At the Annual Meeting on May 15, 2024, 69,715,380 shares were represented (67% quorum). All four proposals presented were approved:
- Election of Director: David L. Fischel was elected as a Class II director.
- Accounting Firm: Ratification of Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2024.
- Stock Incentive Plan: Approval to increase authorized shares by 4,000,000.
- Employee Stock Purchase Plan: Approval to increase authorized shares by 250,000.
Risks, Contingencies, and Outlook
The transaction is subject to significant contingencies, including the successful restructuring of APT's debt and the execution of a lease extension. The deal includes a termination date of December 31, 2024. If the acquisition is not consummated by this date, either party may terminate the agreement. The earnout structure introduces future dilution risk dependent on APT's commercial and regulatory performance through September 30, 2029.
Key Facts for Investor Verification
- Verify the status of APT's debt restructuring and lease extension, as these are explicit closing conditions.
- Monitor the share price volatility, as the final number of shares issued for the acquisition depends on the average closing price near the closing date.
- Review the full text of the Share Purchase Agreement and Voting and Support Agreement, which will be filed as exhibits to the Form 10-Q for the period ending June 30, 2024.
- Assess the potential dilution impact of the estimated 6.1 million shares and the contingent earnout shares.
- Confirm the timeline for the expected third-quarter 2024 closing against the December 31, 2024, termination deadline.